Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis



Status:Recruiting
Conditions:Allergy, Psoriasis, Skin and Soft Tissue Infections, Dermatology, Dermatology, Dermatology
Therapuetic Areas:Dermatology / Plastic Surgery, Otolaryngology
Healthy:No
Age Range:18 - 65
Updated:3/2/2017
Start Date:January 2016
Contact:Vanda Pharmaceuticals
Phone:202-734-3400

Use our guide to learn which trials are right for you!

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

This is a multicenter, randomized, double-blind, placebo-controlled study to be conducted in
the United States in subjects with treatment-resistant pruritus diagnosed with atopic
dermatitis.


Inclusion Criteria:

- Male and non-pregnant, non-lactating female subjects aged 18 - 65 years (inclusive);

- Diagnosed with atopic dermatitis

- Suffering from chronic pruritus with pruritus being actively present

Exclusion Criteria:

- Chronic pruritus due to condition other than atopic dermatitis (AD)

- Participation in a previous tradipitant (LY686017 or VLY-686) trial;

- Anyone affiliated with the site or sponsor and/or anyone who may consent under
duress;

- Any other sound medical reason as determined by the Investigator including any
condition which may lead to an unfavorable risk-benefit of study participation, may
interfere with study compliance or may confound study results.
We found this trial at
6
sites
Wilmington, North Carolina 28401
?
mi
from
Wilmington, NC
Click here to add this to my saved trials
?
mi
from
High Point, NC
Click here to add this to my saved trials
?
mi
from
Miami, FL
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Pflugerville, TX
Click here to add this to my saved trials